Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Bellicum Pharmaceuticals Inc patents


Recent patent applications related to Bellicum Pharmaceuticals Inc. Bellicum Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Bellicum Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Bellicum Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bellicum Pharmaceuticals Inc-related inventors


Methods for controlling t cell proliferation

The technology relates generally to the field of immunology and relates in part to compositions and methods for controlling the proliferation of t cells, for example, therapeutic t cells. The methods further relate to compositions and methods for inducing an immune response in a subject.. ... Bellicum Pharmaceuticals Inc

Modified caspase polypeptides and uses thereof

The technology relates in part to compositions comprising modified caspase-9 polypeptides, compositions comprising nucleic acids coding for modified caspase-9 polypeptides, chimeric modified caspase-9 polypeptides, and methods of use thereof, including methods for cell therapy. Methods for cell therapy include modifying transfused cells to express an inducible modified caspase-9 protein, with reduced basal activity in the absence of the inducer.. ... Bellicum Pharmaceuticals Inc

Dual controls for therapeutic cell activation or elimination

The technology relates in part to methods for controlling the activity or elimination of therapeutic cells using molecular switches that employ distinct heterodimerizer ligands, in conjunction with other multimeric ligands. The technology may be used, for example to activate or eliminate cells used to promote engraftment, to treat diseases or condition, or to control or modulate the activity of therapeutic cells that express chimeric antigen receptors or recombinant t cell receptors.. ... Bellicum Pharmaceuticals Inc

Modified caspase polypeptides and uses thereof

The technology relates in part to compositions comprising modified caspase-9 polypeptides, compositions comprising nucleic acids coding for modified caspase-9 polypeptides, chimeric modified caspase-9 polypeptides, and methods of use thereof, including methods for cell therapy. Methods for cell therapy include modifying transfused cells to express an inducible modified caspase-9 protein, with reduced basal activity in the absence of the inducer.. ... Bellicum Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bellicum Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bellicum Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###